Can a smartphone app tame acid reflux and restore sleep?
NCT ID NCT07744815
First seen Aug 04, 2026 · Last updated Aug 06, 2026 · Updated 2 times
Summary
This study tests whether a mobile app can help people with gastroesophageal reflux disease (GERD) reduce symptom recurrence and improve sleep quality and quality of life. Participants with confirmed GERD will be randomly assigned to either use the app—which provides education, lifestyle and diet tips, breathing exercises, and reminders—or receive standard education. Over eight weeks, researchers will track changes in symptoms, sleep, and daily functioning to see if the app offers added benefits.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- A mobile application providing GERD education, lifestyle and dietary guidance, diaphragmatic breathing exercises, and reminders
- What this could lead to
- If effective, this app could offer a simple, accessible way for people with GERD to reduce symptom flare-ups and improve sleep and daily well-being.
- What could go wrong
- The trial is relatively small and the app's benefits may be modest or not last beyond the study period. Success depends on participants consistently using the app.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
90 people
The number who actually took part.
- Started
-
Sep 2025
- Finished
-
Feb 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18 to 60 years. * Able to communicate in Mandarin Chinese or Taiwanese. -.Owns and is able to use a smartphone. * Endoscopically confirmed gastroesophageal reflux disease with Los Angeles (LA) Classification Grade B, C, or D erosive esophagitis, or Barrett's esophagus. * Able and willing to provide written informed consent. Exclusion Criteria: * Previous esophageal or gastric surgery, including anti-reflux surgery. * Regular use of proton pump inhibitors within the previous 8 weeks. * Receiving antithrombotic therapy. * Diabetes mellitus requiring treatment (HbA1c ≥ 6.5%). * Liver cirrhosis (Child-Pugh class B or higher). * Chronic kidney disease stage 3 or higher. * Neurological disorders affecting participation. * Malignancy other than early-stage cancer. * Hiatal hernia larger than 2 cm.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gastroesophageal reflux esophagitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Yuan's General Hospital
Kaohsiung City, 80249, Taiwan